Mallinckrodt stock rises 23% on sales of its most controversial product By: MarketWatch August 07, 2018 at 10:14 AM EDT The product has been criticized for its high price, or nearly $40,000 a year, and its effectiveness has been questioned. Read More >> Related Stocks: Mallinckrodt plc
